-
281por Mieras, Liesbeth F, Taal, Anna T, van Brakel, Wim H, Cambau, Emmanuelle, Saunderson, Paul R, Smith, W Cairns S, Prakoeswa, Cita Rosita S, Astari, Linda, Scollard, David M, do Nascimento, Dejair Caitano, Grosset, Jacques, Kar, Hemanta K, Izumi, Shinzo, Gillini, Laura, Virmond, Marcos C L, Sturkenboom, Marieke G G“…To define the so called PEP++ regimen for this intervention study, NLR convened an Expert Meeting that was attended by clinical leprologists, public health experts, pharmacologists, dermatologists and microbiologists. The Expert Meeting advised on combinations of available drugs, with known efficacy against leprosy, as well as on the duration of the intake, aiming at a risk reduction of 80–90%. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
282“…To increase the data value in antimicrobial stewardship (AMS)practice, those three surveillance networks are integrated in Shanghai METHODS: The Committee of Rational Use of Antimicrobials and AMS of Shanghai Municipal Health Commission, consisting of health administrators, clinical physicians and microbiologists, clinical pharmacologists and infection control experts, was formed in 2017. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
283por Danjuma, Mohammed Ibn-Mas’ud, Shokri, Shaikha Al, Abubeker, Ibrahim Y., Malik, Ashraf El, Abdallah, Ibtihal Mahmoud Hassan, Shafei, Mohamed Nabil El, Fatima, Haajra, Mahmoud, Mohamed, Hussain, Tanweer, Maghoub, Yahya, Sajid, Jamal, Zouki, Abdel Naser El“…Using the LAAT, and modified Hallas tools, 4 independent raters (2 Clinical Pharmacologists, and 2 General Physicians) assessed and scored the 44 ADR-drug pairs. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
284por Kakkar, Ashish Kumar, Shafiq, Nusrat, Sahni, Neeru, Mohindra, Ritin, Kaur, Navjot, Gamad, Nanda, Panditrao, Aditi, Kondal, Dimple, Malhotra, Samir, Kumar M, Praveen, Rohilla, Rachna, Bhattacharjee, Samiksha, Kumar, Ankit, Bhandari, Ritika Kondel, Pandey, Avaneesh Kumar, Rather, Imraan, Mothsara, Chakrant, Harish, Cvn, Belavagi, Devaraj, Vishwas, Gopal“…A consensus algorithm was developed by a multidisciplinary team consisting of intensivists, internal medicine practitioners, clinical pharmacologists, and infectious disease experts. The tool was piloted by 10 raters belonging to three groups of antimicrobial stewardship (AMS) personnel: Master of Pharmacology (M.Sc.) …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
285por Topperzer, Martha Krogh, Hoffmann, Marianne, Larsen, Hanne Bækgaard, Rosthøj, Susanne, Fridh, Martin Kaj, Roug, Louise Ingerslev, Andres-Jensen, Liv, Pontoppidan, Peter Erik Lokto, Schmiegelow, Kjeld, Sørensen, Jette Led“…Healthcare professionals included nurses, doctors, social workers, physiotherapists, occupational therapists, pharmacists, pharmacologists, dieticians, nursing assistants, and professionals with a supportive function (teachers, secretaries, priests, and daycare workers). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
286por Li, Guangyao, Wang, Ningli, Zhang, Yu, Wei, Wenbin, Lu, Hai, Zhai, Suodi, Zhang, Chao“…The multidisciplinary guideline groups were set up, including ophthalmologists, pharmacists, methodology experts, pharmacologists, pharmacoeconomists, and lawyers. The guideline identified 25 clinical questions included. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
287“…METHODS: This descriptive qualitative study was conducted in 2021 on 46 physicians (including general physicians, specialists, and subspecialists), pharmacologists, microbiologists, and nurses. Participants were purposefully selected from five specialty and subspecialty hospitals in Isfahan, Iran, and the Treatment Administration of Isfahan University of Medical Sciences, Isfahan, Iran. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
288por Bazrafshani, Maliheh Sadat, Pardakhty, Abbas, Kalantari Khandani, Behjat, Tajadini, Haleh, Ghazanfari Pour, Sadra, Hashemi, Sara, Amiri, Shiva, Mehmandoost, Soheil, Beigzadeh, Amin, Abbaszadeh, Samaneh, Sharifi, Hamid“…Oncologists and clinical pharmacologists are recommended to take into account challenges associated with herb-drug interactions in their routine practices, particularly during chemotherapy among these patients. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
289por Eleftheriou, Georgios, Zandonella Callegher, Riccardo, Butera, Raffaella, De Santis, Marco, Cavaliere, Anna Franca, Vecchio, Sarah, Pistelli, Alessandra, Mangili, Giovanna, Bondi, Emi, Somaini, Lorenzo, Gallo, Mariapina, Balestrieri, Matteo, Albert, Umberto“…An interdisciplinary team of experts from different medical specialties (toxicologists, pharmacologists, psychiatrists, gynecologists, neonatologists) was first established to identify the needs underlying the consensus. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
290por Ingrasciotta, Ylenia, Sultana, Janet, Giorgianni, Francesco, Caputi, Achille Patrizio, Arcoraci, Vincenzo, Tari, Daniele Ugo, Linguiti, Claudio, Perrotta, Margherita, Nucita, Andrea, Pellegrini, Fabio, Fontana, Andrea, Cavagna, Lorenzo, Santoro, Domenico, Trifirò, Gianluca“…A list of nephrotoxic drugs was compiled and validated by pharmacologists and nephrologists. The summary of product characteristics was used to classify drugs as ‘contraindicated’ or ‘to be used with caution’ in renal diseases. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
291“…The interviews (n = 13) were carried out with chief pharmacists, MI pharmacists, medication safety officers (pharmacists), chairs of the Medicines Advisory Board (physicians) and clinical pharmacologists (physicians) (participants n = 19). The data was analyzed using descriptive quantitative analysis and qualitative content analysis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
292por Zhang, Feng, Zhang, Tiantian, Gong, Jiahao, Fang, Qinqin, Qi, Shenglan, Li, Mengting, Han, Yan, Liu, Wei, Ge, Guangbo“…Collectively, our findings demonstrate that Styrax can modulate the pharmacokinetic behavior of CYP3A-substrate drugs via inhibiting intestinal CYP3A, which is very helpful for the clinical pharmacologists to better assess the HDIs triggered by Styrax or Styrax-related herbal products.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
293por Raschi, Emanuel, Fusaroli, Michele, Giunchi, Valentina, Repaci, Andrea, Pelusi, Carla, Mollica, Veronica, Massari, Francesco, Ardizzoni, Andrea, Poluzzi, Elisabetta, Pagotto, Uberto, Di Dalmazi, Guido“…Conclusions: We call pharmacologists, internists, oncologists and endocrinologists to raise awareness of serious AI with VEGFR-TKIs, and to develop dedicated guidelines, especially for combination regimens with immunotherapy.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
294“…CONCLUSIONS: OptiMal-PK is designed to be implemented by medicinal chemists and pharmacologists during the pre-clinical anti-malarial drug development phase to explore the impact of different PK/PD parameters upon the predicted clinical activity of any new compound. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
295por Abalde, Samuel, Tenorio, Manuel J., Afonso, Carlos M. L., Uribe, Juan E., Echeverry, Ana M., Zardoya, Rafael“…BACKGROUND: Due to their great species and ecological diversity as well as their capacity to produce hundreds of different toxins, cone snails are of interest to evolutionary biologists, pharmacologists and amateur naturalists alike. Taxonomic identification of cone snails still relies mostly on the shape, color, and banding patterns of the shell. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
296por Juhi, Ayesha, Pipil, Neha, Santra, Soumya, Mondal, Shaikat, Behera, Joshil Kumar, Mondal, Himel“…The responses were checked by two pharmacologists and the consensus output was categorized as “correct” and “incorrect.” …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
297por Cooper, Janine A, Ryan, Cristín, Smith, Susan M, Wallace, Emma, Bennett, Kathleen, Cahir, Caitriona, Williams, David, Teeling, Mary, Fahey, Tom, Hughes, Carmel M“…These criteria underwent a two-round Delphi process, using an expert panel consisting of general practitioners, pharmacists and clinical pharmacologists from the United Kingdom and Republic of Ireland. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
298“…Our approach shows potential to help pharmacologists and clinical trialists narrow the search space for candidate gene/drug associations, including for rare mutations, and for identifying potential drug-repurposing opportunities. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
299por Estarreja, João, Mendes, Priscila, Silva, Carina, Camacho, Pedro, Mateus, Vanessa“…This project has no funding and it has been developed by a multidisciplinary research team of pharmacologists and orthoptists. The study was initiated in May 2021 and it is expected to conclude by the end of 2023. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
300“…To advance the science and enable translation of theranostics worldwide, the Gordon Research Conferences (GRC) organization [www.grc.org] has selected the authors to organize a 5-day inaugural meeting on Radionuclide Theranostics for the Management of Cancer in June 2020 [https://www.grc.org/radionuclide-theranostics-for-the-management-of-cancer-conference/2020/]that brings together cancer biologists, radiation physicists, receptor pharmacologists, nuclear medicine physicians, and industry representatives to 1) Identify new molecular targets and targeting vectors for specific malignancies; 2) Explore development of novel radionuclides and molecularly targeted radiopharmaceuticals; and 3) Optimize therapeutic benefits based on an understanding of radionuclide risks to normal tissues. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto